Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGB1 | P09429 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | BID | P55957 | 3/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 3/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.43 |
| ▸ | BAK1 | Q16611 | 3/20 | 0.43 |
| ▸ | F7 | P08709 | 3/20 | 0.43 |
| ▸ | F3 | P13726 | 3/20 | 0.43 |
| ▸ | MMP2 | P08253 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ECE1 | P42892 | 1/20 | 0.43 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 0.43 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.43 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.43 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.43 |
| ▸ | ALB | P02768 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16240898 | 1.00 | HMGB1 (0.62) | HMGB1KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL8395993 | 1.00 | HMGB1 (0.62) | HMGB1KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL31354821 | 1.00 | HMGB1 (0.62) | HMGB1KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL5056707 | 0.91 | ALDH1A1 (0.52) | HMGB1KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL2817104 | 0.86 | FOLH1 (0.54) | HMGB1KDM4EHSD17B10ALDH1A1BID | |
| SCHEMBL2817110 | 0.86 | FOLH1 (0.54) | HMGB1KDM4EHSD17B10ALDH1A1BID | |
| SCHEMBL23748665 | 0.85 | HMGB1 (0.43) | HMGB1KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL30853556 | 0.85 | HMGB1 (0.46) | HMGB1KDM4EHSD17B10ALDH1A1BID | |
| SCHEMBL7950463 | 0.84 | G6PD (0.47) | HMGB1KDM4EHSD17B10ALDH1A1BID | |
| SCHEMBL18604012 | 0.84 | G6PD (0.47) | HMGB1KDM4EHSD17B10ALDH1A1BID |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10434485-B2 | Compositions comprising encapsulated actives within droplets and other compartments | THE PROCTER & GAMBLE COMPANY (US) | 2019-10-08 | — | — | US | claimed |
| US-9878299-B2 | Methods for encapsulation of actives within droplets and other compartments | THE PROCTER & GAMBLE COMPANY (US) | 2018-01-30 | — | — | US | claimed |
| US-20170296996-A1 | Compositions Comprising Encapsulated Actives within Droplets and other Compartments | PROCTER & GAMBLE (US) | 2017-10-19 | — | — | US | claimed |
| EP-3223801-A1 | METHODS FOR ENCAPSULATION OF ACTIVES WITHIN DROPLETS AND OTHER COMPARTMENTS | The Procter & Gamble Company (US) | 2017-10-04 | — | — | EP | claimed |
| EP-3223800-A1 | COMPOSITIONS COMPRISING ENCAPSULATED ACTIVES WITHIN DROPLETS AND OTHER COMPARTMENTS | The Procter & Gamble Company (US) | 2017-10-04 | — | — | EP | claimed |
| US-9718044-B2 | Compositions comprising encapsulated actives within droplets and other compartments | THE PROCTER & GAMBLE COMPANY (US) | 2017-08-01 | — | — | US | claimed |
| WO-2016085740-A1 | COMPOSITIONS COMPRISING ENCAPSULATED ACTIVES WITHIN DROPLETS AND OTHER COMPARTMENTS | THE PROCTER & GAMBLE COMPANY (US) | 2016-06-02 | — | — | WO | claimed |
| WO-2016085742-A1 | METHODS FOR ENCAPSULATION OF ACTIVES WITHIN DROPLETS AND OTHER COMPARTMENTS | THE PROCTER & GAMBLE COMPANY (US) | 2016-06-02 | — | — | WO | claimed |
| US-20160144330-A1 | Methods for Encapsulation of Actives within Droplets and other Compartments | THE PROCTER & GAMBLE COMPANY | 2016-05-26 | — | — | US | claimed |
| US-20160145535-A1 | Compositions Comprising Encapsulated Actives within Droplets and other Compartments | THE PROCTER & GAMBLE COMPANY | 2016-05-26 | — | — | US | claimed |
| US-12590264-B2 | Profragrance conjugates | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2026-03-31 | — | — | US | disclosed |
| EP-4433483-B1 | FRAGRANCE SUBSTANCES AND FORMULATION CONTAINING THEM | INT FLAVORS & FRAGRANCES INC (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-4659819-A2 | A NOVEL FURAN COMPOUND AND ITS USE IN FRAGRANCE FORMULATIONS | International Flavors & Fragrances Inc. (US) | 2025-12-10 | — | — | EP | disclosed |
| US-12428609-B2 | Organoleptic compounds | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-09-30 | — | — | US | disclosed |
| EP-4416137-B1 | A NOVEL FURAN COMPOUND AND ITS USE IN FRAGRANCE FORMULATIONS | INT FLAVORS & FRAGRANCES INC (US) | 2025-07-23 | — | — | EP | disclosed |
| US-20120207698-A1 | NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2012-08-16 | — | — | US | disclosed |
| US-20120183490-A1 | NOVEL 1,3-OXATHIANE COMPOUNDS AND THEIR USE IN FLAVOR AND FRAGRANCE COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2012-07-19 | — | — | US | disclosed |
| US-8114823-B2 | Isomers of bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, ethyl ester and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2012-02-14 | — | — | US | disclosed |
| US-20120010301-A1 | ORGANOLEPTIC COMPOUNDS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2012-01-12 | — | — | US | disclosed |
| US-20120004326-A1 | ISOMERS OF BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID, ETHYL ESTER AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590264-B2 | Profragrance conjugates | TRPA1, TST, HSF1 | HMGB1 4234/4885KDM4E 4682/4885HSD17B10 1568/4885 |
| US-12428609-B2 | Organoleptic compounds | TRPA1, TRPV1, TRPV5 | HMGB1 3051/4885KDM4E 2148/4885HSD17B10 630/4885 |
| US-20120004326-A1 | ISOMERS OF BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID, ETHYL ESTER AND THEIR USE IN PERFUME COMPOSITIONS | ELOVL5, CYP8B1, CYP1B1 | HMGB1 4647/4885KDM4E 2987/4885HSD17B10 124/4885 |
| US-20120207698-A1 | NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN PERFUME COMPOSITIONS | DPYD, TYMP, IMPDH1 | HMGB1 1910/4885KDM4E 3580/4885HSD17B10 1756/4885 |
| US-20120183490-A1 | NOVEL 1,3-OXATHIANE COMPOUNDS AND THEIR USE IN FLAVOR AND FRAGRANCE COMPOSITIONS | TAS1R1, TAS2R1, TAS1R3 | HMGB1 3234/4885KDM4E 1298/4885HSD17B10 765/4885 |
| US-20120010301-A1 | ORGANOLEPTIC COMPOUNDS | TRPA1, OR51E2, OR10J3 | HMGB1 4765/4885KDM4E 475/4885HSD17B10 315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.